Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v19-EN Version v15-EN
Language English English
Date Updated 2020-11-27 2020-08-31
Drug Identification Number 02166720 02166720
Brand name SANDOZ TIMOLOL SANDOZ TIMOLOL
Common or Proper name TIMOLOL TIMOLOL
Company Name SANDOZ CANADA INCORPORATED SANDOZ CANADA INCORPORATED
Ingredients TIMOLOL TIMOLOL
Strength(s) 0.5% 0.5%
Dosage form(s) SOLUTION SOLUTION
Route of administration OPHTHALMIC OPHTHALMIC
Packaging size 5ml 5ml
ATC code S01ED S01ED
ATC description ANTIGLAUCOMA PREPARATIONS AND MIOTICS ANTIGLAUCOMA PREPARATIONS AND MIOTICS
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date
Actual start date 2019-08-19 2019-08-19
Estimated end date 2020-12-25 2020-12-04
Actual end date
Shortage status Actual shortage Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments